EpiHeart is a pioneering medical device company creating foundation for surgical administration of advanced cell therapies. We are a University spin-off company leveraging over 10 years of dedicated research conducted on three continents. 

The two key factors that led to the founding of EpiHeart were the wish to develop new cardiac treatments that give the patients more life years and enhance their quality of life, and the wish to create a profitable and rapidly growing medical technology company that would enable these treatments to be used extensively. Our home is Helsinki, Finland, where we continue collaboration with University of Helsinki, Helsinki University Hospital "HUS" and Aalto University.   

Since the founding of the company, the team has had solid medical and entrepreneurial knowledge and the team has been strengthened along the way with regulatory and product development professionals. EpiHeart develops and manufactures the medical devices in compliance with the ISO 13485:2016 standard.